 |
|
|
| |
Prolonged RNA interference therapy with ARC-520 Injection in treatment naïve, HBeAg positive and negative patients with chronic HBV results in significant reductions of HBs antigen
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Man-Fung Yuen* 1, Kevin Liu1, Henry L. Chan2, Bruce D. Given3, Thomas Schluep3, James Hamilton3, Ching-Lung Lai1, Stephen A. Locarnini4, Johnson Y. Lau1, 5, Carlo Ferrari6, Robert G. Gish7, 8
1The University of Hong Kong, 2The Chinese University of Hong Kong, Hong Kong, Hong Kong, China, 3Arrowhead Pharmaceuticals, Pasadena, United States, 4Victorian Infectious Diseases Reference Laboratory, Victoria, Australia, 5Hong Kong Polytechnic University, Hong Kong, Hong Kong, China, 6University of Parma, Parma, Italy, 7Stanford University, Palo Alto, 8Hepatitis B Foundation, Doylestown, United States
|
| |
|
|
|
|
|
